SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 118 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $7,219,000 | -5.5% | 77,800 | -30.0% | 0.07% | -13.8% |
Q3 2014 | $7,641,000 | -34.4% | 111,100 | 0.0% | 0.08% | -41.6% |
Q2 2014 | $11,643,000 | +26.3% | 111,100 | 0.0% | 0.14% | +21.2% |
Q1 2014 | $9,218,000 | +9.6% | 111,100 | -14.5% | 0.11% | -8.9% |
Q4 2013 | $8,414,000 | +2.1% | 130,000 | 0.0% | 0.12% | -15.6% |
Q3 2013 | $8,241,000 | – | 130,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
Tradeworx Inc. | 2,936 | $308,000 | 0.25% |